Daven Henze discusses how air pollution spreads across the globe and what policymakers are doing in response.
New Research In
Physical Sciences
Featured Portals
Articles by Topic
Biological Sciences
Featured Portals
Articles by Topic
Edited by Anthony S. Fauci, National Institute of Allergy and Infectious Diseases, Bethesda, MD, and approved June 19, 2014 (received for review March 19, 2014)
Significance
For more than three decades since the discovery of HIV-1, AIDS remains a major public health problem affecting greater than 35.3 million people worldwide. Current antiretroviral therapy has failed to eradicate HIV-1, partly due to the persistence of viral reservoirs. RNA-guided HIV-1 genome cleavage by the Cas9 technology has shown promising efficacy in disrupting the HIV-1 genome in latently infected cells, suppressing viral gene expression and replication, and immunizing uninfected cells against HIV-1 infection. These properties may provide a viable path toward a permanent cure for AIDS, and provide a means to vaccinate against other pathogenic viruses. Given the ease and rapidity of Cas9/guide RNA development, personalized therapies for individual patients with HIV-1 variants can be developed instantly.
Abstract
AIDS remains incurable due to the permanent integration of HIV-1 into the host genome, imparting risk of viral reactivation even after antiretroviral therapy. New strategies are needed to ablate the viral genome from latently infected cells, because current methods are too inefficient and prone to adverse off-target effects. To eliminate the integrated HIV-1 genome, we used the Cas9/guide RNA (gRNA) system, in single and multiplex configurations. We identified highly specific targets within the HIV-1 LTR U3 region that were efficiently edited by Cas9/gRNA, inactivating viral gene expression and replication in latently infected microglial, promonocytic, and T cells. Cas9/gRNAs caused neither genotoxicity nor off-target editing to the host cells, and completely excised a 9,709-bp fragment of integrated proviral DNA that spanned from its 5′ to 3′ LTRs. Furthermore, the presence of multiplex gRNAs within Cas9-expressing cells prevented HIV-1 infection. Our results suggest that Cas9/gRNA can be engineered to provide a specific, efficacious prophylactic and therapeutic approach against AIDS.
Footnotes
↵1W.H. and R.K. contributed equally to this work.
- ↵2To whom correspondence may be addressed. Email: kamel.khalili{at}temple.edu or wenhui.hu{at}temple.edu.
Author contributions: W.H., R.K., and K.K. designed research; W.H., R.K., F.Y., Y.Z., L.C., F.L., and B.L. performed research; D.A.-C., Y.G.-M., J.K., and X.M. contributed new reagents/analytic tools; W.H., B.L., and K.K. analyzed data; and W.H. and K.K. wrote the paper.
Conflict of interest statement: A patent application has been filed relating to this work.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1405186111/-/DCSupplemental.
Genome editing eradicates HIV-1
Sign up for Article Alerts
Jump to section
You May Also be Interested in
Some researchers are aiming to apply the technique to a range of hard-to-treat maladies, including severe obsessive compulsive disorder, Tourette syndrome, and Alzheimer’s disease.
Image credit: Helen Mayberg.
Can a computer actually produce something new rather than merely emulating human artists? If nothing else, they are making some types of art more accessible for would-be artists.
Image credit: Roman Verostko (artist).
PNAS Profile of NAS member and geologist Paul E. Olsen.
Image courtesy of Kevin Krajick (Columbia University, New York).
Fossil evidence helps address a longstanding debate on the evolution of hagfish, a jawless, marine-dwelling slime “eel,” and suggests that living jawless vertebrates may not be as primitive as their anatomy suggests.
Image courtesy of Tetsuto Miyashita.
More Articles of This Classification
Biological Sciences
Medical Sciences
Related Content
Cited by...
- In Vivo Blunt-End Cloning Through CRISPR/Cas9-Facilitated Non-Homologous End-Joining
- HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site
- Modulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process
- Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency
- Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci
- Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance
- FISHing Out the Hidden Enemy: Advances in Detecting and Measuring Latent HIV-Infected Cells
- Overview of CRISPR-Cas9 Biology
- Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy
- Attacking HIV-1 RNA versus DNA by sequence-specific approaches: RNAi versus CRISPR-Cas
- Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
- What is CRISPR/Cas9?
- The clinical applications of genome editing in HIV
- Core Concept: CRISPR gene editing
- CRISPR-Cas9: a new and promising player in gene therapy
- The new frontier of genome engineering with CRISPR-Cas9